| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |